These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 28446404)
1. [Irbesartan ameliorates cardiac inflammation in type 2 diabetic db/db mice]. Ye XL; Huang WC; Zheng YT; Liang Y; Gong WQ; Yang CM; Liu B Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):505-511. PubMed ID: 28446404 [TBL] [Abstract][Full Text] [Related]
2. [Effects of irbesartan on nitric oxide system in the heart of diabetic rats]. Qian XX; Chen YM; Wu WK; Liu Y; Zhou B; Liu JL; Chen L Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1359-62. PubMed ID: 16982456 [TBL] [Abstract][Full Text] [Related]
3. [Effect of irbesartan on ACE2 expression in diabetic rat myocardium]. Hu YY; Shen J; Zhu Y; Tang JL; Liu S Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1336-8. PubMed ID: 20584672 [TBL] [Abstract][Full Text] [Related]
4. [The mechanism of irbesartan against diabetes induced myocardial fibrosis in rat model]. Zhang GJ; Zhang WP; Wang KC; Yu Y; Xie XF; Gao Q Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Mar; 32(3):221-224. PubMed ID: 29931880 [TBL] [Abstract][Full Text] [Related]
5. Irbesartan attenuates TNF-α-induced ICAM-1, VCAM-1, and E-selectin expression through suppression of NF-κB pathway in HUVECs. Jiang Y; Jiang LL; Maimaitirexiati XM; Zhang Y; Wu L Eur Rev Med Pharmacol Sci; 2015 Sep; 19(17):3295-302. PubMed ID: 26400537 [TBL] [Abstract][Full Text] [Related]
6. Irbesartan ameliorates diabetic nephropathy by reducing the expression of connective tissue growth factor and alpha-smooth-muscle actin in the tubulointerstitium of diabetic rats. Ren X; Guan G; Liu G; Liu G Pharmacology; 2009; 83(2):80-7. PubMed ID: 19065061 [TBL] [Abstract][Full Text] [Related]
7. Dapagliflozin Ameliorates STZ-Induced Cardiac Hypertrophy in Type 2 Diabetic Rats by Inhibiting the Calpain-1 Expression and Nuclear Transfer of NF- Liu L; Luo H; Liang Y; Tang J; Shu Y Comput Math Methods Med; 2022; 2022():3293054. PubMed ID: 35096128 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice. Kato J; Koda M; Kishina M; Tokunaga S; Matono T; Sugihara T; Ueki M; Murawaki Y Int J Mol Med; 2012 Jul; 30(1):107-13. PubMed ID: 22469867 [TBL] [Abstract][Full Text] [Related]
9. [Effects of electroacupuncture on inflammatory response of cardiac muscle tissue in mice with acute myocardial ischemia]. Wang J; Yuan J; Cai Y; Fu S; Li M; Hong H; Lu S; Zhu B Zhongguo Zhen Jiu; 2018 May; 38(5):5133-8. PubMed ID: 29797917 [TBL] [Abstract][Full Text] [Related]
10. Calycosin Ameliorates Diabetes-Induced Renal Inflammation via the NF-κB Pathway In Vitro and In Vivo. Zhang YY; Tan RZ; Zhang XQ; Yu Y; Yu C Med Sci Monit; 2019 Mar; 25():1671-1678. PubMed ID: 30830898 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure. Watanabe R; Suzuki J; Wakayama K; Kumagai H; Ikeda Y; Akazawa H; Komuro I; Isobe M Hypertens Res; 2016 Apr; 39(4):237-44. PubMed ID: 26657004 [TBL] [Abstract][Full Text] [Related]
12. Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats. Russell JC; Kelly SE; Vine DF; Proctor SD Br J Pharmacol; 2009 Nov; 158(6):1588-96. PubMed ID: 19814728 [TBL] [Abstract][Full Text] [Related]
13. Influence of irbesartan on expression of ILK and its relationship with epithelial-mesenchymal transition in mice with unilateral ureteral obstruction. Liu BC; Xia HL; Wu JN; Zhang XL; Liu DG; Gong YX Acta Pharmacol Sin; 2007 Nov; 28(11):1810-8. PubMed ID: 17959033 [TBL] [Abstract][Full Text] [Related]
14. Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway. Cheng YZ; Yang SL; Wang JY; Ye M; Zhuo XY; Wang LT; Chen H; Zhang H; Yang L Life Sci; 2018 Jul; 205():184-192. PubMed ID: 29702126 [TBL] [Abstract][Full Text] [Related]
15. Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism. Westermann D; Rutschow S; Jäger S; Linderer A; Anker S; Riad A; Unger T; Schultheiss HP; Pauschinger M; Tschöpe C Diabetes; 2007 Mar; 56(3):641-6. PubMed ID: 17327431 [TBL] [Abstract][Full Text] [Related]
16. Targeting the proinflammatory cytokines, oxidative stress, apoptosis and TGF-β1/STAT-3 signaling by irbesartan to ameliorate doxorubicin-induced hepatotoxicity. Kabel AM; Alzahrani AA; Bawazir NM; Khawtani RO; Arab HH J Infect Chemother; 2018 Aug; 24(8):623-631. PubMed ID: 29753615 [TBL] [Abstract][Full Text] [Related]
17. [Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis]. Qian H; Liu L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):509-12. PubMed ID: 24796747 [TBL] [Abstract][Full Text] [Related]
18. Effect of Chinese herbal compound Naofucong () on the inflammatory process induced by high glucose in BV-2 cells. Jing GC; Zhang MR; Ji C; Zuo PP; Liu YQ; Gu B Chin J Integr Med; 2016 Nov; 22(11):832-839. PubMed ID: 27225293 [TBL] [Abstract][Full Text] [Related]
19. Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice. Chen XW; Du XY; Wang YX; Wang JC; Liu WT; Chen WJ; Li HY; Peng FF; Xu ZZ; Niu HX; Long HB Mediators Inflamm; 2016; 2016():1405924. PubMed ID: 26880862 [TBL] [Abstract][Full Text] [Related]
20. Alkannin Inhibited Hepatic Inflammation in Diabetic Db/Db Mice. Xue W; Fan Z; Li Y; Li L; Zhang T; Lu J; Ma B; Zhu Z; Lian J; Zhang C; Song X; Sun D; Zhai Y; Fan R; Cao Y; Deng X; Zhao J Cell Physiol Biochem; 2018; 45(6):2461-2470. PubMed ID: 29554661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]